Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MPI | P34949 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.39 |
| ▸ | ACACA | Q13085 | 2/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL346901 | 1.00 | CYP11B1 (0.56) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL13049747 | 0.97 | CYP11B1 (0.53) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL13458897 | 0.97 | CYP11B1 (0.53) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL22101164 | 0.92 | CYP11B1 (0.51) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL1543078 | 0.90 | CYP11B1 (0.50) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL9976745 | 0.89 | CYP11B1 (0.51) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL13458690 | 0.88 | CYP11B1 (0.53) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL18101983 | 0.87 | HPRT1 (0.45) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL16696480 | 0.86 | CYP11B1 (0.47) | CYP11B1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL14581511 | 0.84 | CYP11B1 (0.45) | CYP11B1ALDH1A1MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3055891-B1 | SEMICONDUCTING MATERIAL COMPRISING A PHOSPHINE OXIDE MATRIX AND METAL SALT | NOVALED GMBH (DE) | 2024-10-30 | — | — | EP | disclosed |
| US-20240298524-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NOVALED GMBH (DE) | 2024-09-05 | — | — | US | disclosed |
| CN-113563379-B | Semiconductor material comprising a phosphine oxide matrix and a metal salt | 诺瓦尔德股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-3281238-B1 | SEMICONDUCTING MATERIAL COMPRISING A PHOSPHINE OXIDE MATRIX AND METAL SALT | NOVALED GMBH (DE) | 2024-04-24 | — | — | EP | disclosed |
| CN-111900255-B | Organic light emitting device comprising a polar matrix, a metal dopant and a silver cathode | 诺瓦尔德股份有限公司 | 2024-03-15 | — | — | CN | disclosed |
| EP-3374538-B1 | PROCESS FOR MAKING A METAL CONTAINING LAYER | NOVALED GMBH (DE) | 2024-02-21 | — | — | EP | disclosed |
| CN-108292706-B | Metal layer comprising alkali metal and second metal | 诺瓦尔德股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-3259786-B1 | SEMICONDUCTING MATERIAL AND NAPHTOFURANE MATRIX COMPOUND FOR IT | NOVALED GMBH (DE) | 2023-08-30 | — | — | EP | disclosed |
| US-11355721-B2 | Organic light emitting device comprising polar matrix, metal dopant and silver cathode | NOVALED GMBH (DE) | 2022-06-07 | — | — | US | disclosed |
| US-11309495-B2 | Semiconducting material comprising a phosphine oxide matrix and metal salt | NOVALED GMBH (DE) | 2022-04-19 | — | — | US | disclosed |
| EP-3561876-B1 | DISPLAY | NOVALED GMBH (DE) | 2022-02-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11309495-B2 | Semiconducting material comprising a phosphine oxide matrix and metal salt | C1S, C5, SLC26A3 | CYP11B1 3359/4885ALDH1A1 2484/4885MEN1 220/4885 |
| US-20240298524-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NNMT, PNN, PNMT | CYP11B1 4407/4885ALDH1A1 3986/4885MEN1 230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.